NASDAQ:IKT | Key Financial Ratios | Inhibikase Therapeutics, Inc.

Complete source-backed ratio history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-06-3015.82-37.07%-39.55%
2026-03-3130.14-29.40%-30.40%
2025-12-3121.7-26.63%-27.91%
2025-09-3011.73-59.87%-65.37%
2025-06-3010.09-46.71%-51.85%
2025-03-3111.01-38.77%-42.63%
2024-12-3126.37-27.91%-29.01%
2024-09-300.85-447.01%3687.44%
2024-06-302.32-208.26%-360.68%
2024-03-312.55-173.48%-283.34%
2023-12-314.13-131.17%-173.34%
2023-09-306.4-106.99%-127.38%
2023-06-308.04-85.15%-97.77%
2023-03-3110.37-63.53%-70.76%
2022-12-316.59-72.40%-85.83%
2022-09-308.71-65.84%-74.86%
2022-06-30-55.29%-63.70%
2022-03-31-43.73%-49.37%
2021-12-3110.47-34.82%-38.49%
2021-09-30-23.88%-25.38%
2021-06-30-14.53%-15.20%
2021-03-313.31-41.58%-61.44%
2020-12-313.13-19.27%-29.11%

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-12-3121.7-26.63%-27.91%
2024-12-3126.37-27.91%-29.01%
2023-12-314.13-131.17%-173.34%
2022-12-316.59-72.40%-85.83%
2021-12-3110.47-34.82%-38.49%
2020-12-31-19.27%-29.11%